PT1493435E - Composições de libertação controlada de beta-histina - Google Patents

Composições de libertação controlada de beta-histina Download PDF

Info

Publication number
PT1493435E
PT1493435E PT03015172T PT03015172T PT1493435E PT 1493435 E PT1493435 E PT 1493435E PT 03015172 T PT03015172 T PT 03015172T PT 03015172 T PT03015172 T PT 03015172T PT 1493435 E PT1493435 E PT 1493435E
Authority
PT
Portugal
Prior art keywords
betahistine
controlled release
release compositions
optionally
coating layer
Prior art date
Application number
PT03015172T
Other languages
English (en)
Inventor
Flavio Fossati
Anna Perachiotti
Marco Carnaghi
Luciano Marcelloni
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Publication of PT1493435E publication Critical patent/PT1493435E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
PT03015172T 2003-07-04 2003-07-04 Composições de libertação controlada de beta-histina PT1493435E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03015172A EP1493435B1 (en) 2003-07-04 2003-07-04 Controlled Release Compositions of Betahistine

Publications (1)

Publication Number Publication Date
PT1493435E true PT1493435E (pt) 2008-08-14

Family

ID=33427119

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03015172T PT1493435E (pt) 2003-07-04 2003-07-04 Composições de libertação controlada de beta-histina

Country Status (17)

Country Link
EP (1) EP1493435B1 (pt)
CN (1) CN1816323A (pt)
AT (1) ATE395048T1 (pt)
CY (1) CY1108551T1 (pt)
DE (1) DE60320965D1 (pt)
DK (1) DK1493435T3 (pt)
EA (1) EA011569B1 (pt)
EC (1) ECSP066267A (pt)
ES (1) ES2306827T3 (pt)
GE (1) GEP20084349B (pt)
LT (1) LT5379B (pt)
MX (1) MXPA06000090A (pt)
PL (1) PL379374A1 (pt)
PT (1) PT1493435E (pt)
SI (1) SI1493435T1 (pt)
TN (1) TNSN05326A1 (pt)
WO (1) WO2005004850A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CN102046170B (zh) 2008-05-27 2012-11-28 墨尔本大学 治疗患有咽鼓管功能障碍的哺乳动物的方法
DE102012105528A1 (de) * 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
PT3431078T (pt) * 2017-07-20 2021-04-21 Intas Pharmaceuticals Ltd Composições orais sólidas de libertação prolongada não pulsáteis de betaistina
CN111249237A (zh) * 2019-12-21 2020-06-09 乐普恒久远药业有限公司 盐酸倍他司汀药物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (pt) 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
IT1229237B (it) 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
GB9104854D0 (en) * 1991-03-07 1991-04-17 Reckitt & Colmann Prod Ltd Sustained release compositions
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
IT1309591B1 (it) * 1999-03-05 2002-01-24 Formenti Farmaceutici Spa Composizioni a rilascio controllato di betaistina.

Also Published As

Publication number Publication date
EA200501908A1 (ru) 2006-08-25
PL379374A1 (pl) 2006-09-04
EA011569B1 (ru) 2009-04-28
EP1493435A1 (en) 2005-01-05
GEP20084349B (en) 2008-04-10
ATE395048T1 (de) 2008-05-15
LT2006009A (en) 2006-06-27
DK1493435T3 (da) 2008-09-08
ES2306827T3 (es) 2008-11-16
MXPA06000090A (es) 2006-04-07
LT5379B (lt) 2006-10-25
EP1493435B1 (en) 2008-05-14
CY1108551T1 (el) 2014-04-09
DE60320965D1 (de) 2008-06-26
TNSN05326A1 (en) 2007-07-10
WO2005004850A1 (en) 2005-01-20
SI1493435T1 (sl) 2008-10-31
CN1816323A (zh) 2006-08-09
ECSP066267A (es) 2006-07-28

Similar Documents

Publication Publication Date Title
LT2006009A (en) Controlled release compositions of betahistine
WO2007000778A3 (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
BR0002880A (pt) Composição farmacêutica de liberação controlada termoformável sólida
BRPI0509194A (pt) formulação e método de comprimido revestido
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
ATE273745T1 (de) Verfahren zur herstellung aktivstoffhaltiger kapseln mit ultradünner wandschicht
DE60211464D1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
ATE258044T1 (de) Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs
PT885014E (pt) Composicoes farmaceuticas contendo polimeros orto ester tamponados
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
NO20032737L (no) Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av ivabradin
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
HRP20090190T1 (en) Pharmaceutical composition comprising a salt of mirtazapine
BR0008739A (pt) Composições de liberação controlada debeta-histina
ITTO20000613A0 (it) Polimeri organici antiriflettenti per rivestimenti e loro procedimento di preparazione.
GB2374078B (en) Organic anti-reflective coating polymers, anti-reflective coating composition comprising the same and preparation methods thereof
WO2003096874A3 (en) Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
WO2008122994A3 (en) Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
GB2364316B (en) Organic anti-reflective coating polymer, anti-reflective coating composition and methods of preparation thereof
BR0115206A (pt) Composições hidroliticamente instáveis
DE60221787D1 (de) Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil
WO2009047800A3 (en) Oral controlled release composition of carvedilol
ECSP003358A (es) Composiciones de betahistina de liberacion controlada
UY27017A1 (es) Composiciones hidrolíticamente inestables